Tag: Spdr S&P Biotech Etf

Jim Cramer says this former Covid market darling is finally investable again

French biotech stock soars 31% after new data on experimental medicine

Biotech IPO window is opening but big pharma M&A still sets the pace, top bankers tell CNBC

Drugmakers race to find a place in the next wave of obesity drugs

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

GSK in talks to acquire Nuvalent for more than $9 billion in biggest deal in over a decade: FT

‘Buying stuff like it’s going out of fashion’: Biotech M&A on track for best year since pre-Covid

Hantavirus cases spark surge in pharma and biotech stocks — here’s why

Pharma bets a little-known form of cholesterol will underpin its next blockbuster heart drugs

Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion